Stuart Gibb, Ph.D Email & Phone Number
@terumobct.com
LinkedIn matched
Who is Stuart Gibb, Ph.D? Overview
A concise factual answer block for searchers comparing this professional profile.
Stuart Gibb, Ph.D is listed as Patients first | Cell and Gene therapies | Ph.D Neuroscientist at Kyverna Therapeutics, a with 22 employees, based in San Francisco Bay Area, United States. AeroLeads shows a work email signal at terumobct.com and a matched LinkedIn profile for Stuart Gibb, Ph.D.
Stuart Gibb, Ph.D previously worked as Scientific Affairs Lead - Cell Therapy, IIT • Clinical IIT Group at Kyverna Therapeutics and Head of Scientific Strategy | Cell and Gene therapies at Terumo Blood And Cell Technologies. Stuart Gibb, Ph.D holds Doctor Of Philosophy (Ph.D.), Neuroscience from University Of Cambridge.
Email format at Kyverna Therapeutics
This section adds company-level context without repeating Stuart Gibb, Ph.D's masked contact details.
AeroLeads found 1 current-domain work email signal for Stuart Gibb, Ph.D. Compare company email patterns before reaching out.
About Stuart Gibb, Ph.D
A passionate advocate for Cell and Gene Therapy, I am particularly interested in the continuous advancements and possibilities of CAR-T therapies. Additionally, I am captivated by the potential medical breakthroughs promised by exploring CAR-moieties with cell types such as gd-T cells and Macrophages, The promise of iPSCs for allogeneic therapies and use of viral vectors for in vivo CAR-generation further intrigue me. Cell therapy is just getting going, there is much to do and people to help.
Listed skills include Neuronal Cultures, Primary Cells, Molecular Biology, Cell Culture, and 30 others.
Stuart Gibb, Ph.D's current company
Company context helps verify the profile and gives searchers a useful next step.
Stuart Gibb, Ph.D work experience
A career timeline built from the work history available for this profile.
Head Of Scientific Strategy | Cell And Gene Therapies
Medical Science Liaison
Cognoa is a pediatric behavioral health company developing digital diagnostic and therapeutic products with the goals of enabling equitable access to care and improving the lives and outcomes of children and families living with behavioral health conditions, starting with autism.
Senior Field Application Scientist
Field Application Scientist
Scientific support and trainer for TerumoBCT’s portfolio of cell therapy devices in North America. Portfolio includes the Quantum bioreactor platform, the FINIA device for cryopreservation and the COBE 2991 blood component separation device.I provide customers with a complete support package from the initial translation of customer needs for automation and GMP documentation to a training scheme and in-depth problem solving.Specialist for the production of Stem Cells, T-Cells and Viral Vectors with the Quantum platform.I enjoy the team environment and work closely with sales and marketing teams to engage customers andset expectations for success.
Head Of Cell Biology
Head of the department of cell biology. Responsible for delivery of Magnelle contrast and genetic editing agents to therapeutic cells. Magnelles, non-pathogenic magnetotactic bacteria are magnetic resonance imaging (MRI) beacons. Magnelles can be incorporated into eukaryotic cells, allowing for non-invasive tracking of transplanted cells in vivo using standard MRI instruments. Magnelles can also be engineered to deliver the CRISPR system and provide genetic edits.
Scientist
Lead scientist evaluating proteins released by Mesenchymal Stem Cells (MSCs) as ‘cell free’ therapeutics for Traumatic Brain Injury. Head of lab operations for stem cell therapies. Developed production and evaluation protocols for the Quantum bioreactor platform. Scientific consultant for drug master file development. Scientific Investigator for biomarkers indicating outcomes following Traumatic Brain Injury
Molecular And Cellular Biology Scientist
Scientist investigating the role of Src kinases in alcohol addiction. Developed Adenoviral, Lentviral and AAV viral vector platforms for delivery of shRNA and mutant protein coding sequences in vivo. Developed cell-based assays for neurotransmitter release to address questions on aberrant activity.
Fellow
Lead scientist for glutamate transporter dysfunction in ALS. Utilized the G93A ALS mouse model, organotypic and primary cultures along with a multitude of molecular biology techniques, determined that caspase cleavage of the transporter was the root cause. Uncovered aberrant fragment processing of the caspase cleaved C-terminal fragment by SUMO and novel electrophysiological properties for the N-terminal fragment that remains in the membrane, finding that both events contribute to pathology in a mouse model of the disease.
Colleagues at Kyverna Therapeutics
Other employees you can reach at kyvernatx.com. View company contacts for 22 employees →
Heather Hughes
Colleague at Kyverna TherapeuticsBellevue, Washington, United States
View →
TH
Tracy Hill
Colleague at Kyverna TherapeuticsSan Francisco Bay Area, United States
View →
CI
Carrie Iriki
Colleague at Kyverna TherapeuticsSan Francisco, California, United States
View →
SD
Sham Dholakia
Colleague at Kyverna TherapeuticsUnited States
View →
RB
Russ Bowes
Colleague at Kyverna TherapeuticsMill Spring, North Carolina, United States
View →
TL
Tatum Laird
Colleague at Kyverna TherapeuticsLos Angeles, California, United States
View →
AC
Ames C. Register
Colleague at Kyverna TherapeuticsSan Francisco Bay Area, United States
View →
EN
Esther Nie, Md, Phd
Colleague at Kyverna TherapeuticsSan Francisco, California, United States
View →
TA
Trujillo Adan Ricardo
Colleague at Kyverna TherapeuticsSan Gabriel, California, United States
View →
YM
Yiwei M.
Colleague at Kyverna TherapeuticsSan Francisco Bay Area, United States
View →
Stuart Gibb, Ph.D education
Doctor Of Philosophy (Ph.D.), Neuroscience
Bachelor Of Science (B.Sc.), Neuroscience
Frequently asked questions about Stuart Gibb, Ph.D
Quick answers generated from the profile data available on this page.
What company does Stuart Gibb, Ph.D work for?
Stuart Gibb, Ph.D works for Kyverna Therapeutics.
What is Stuart Gibb, Ph.D's role at Kyverna Therapeutics?
Stuart Gibb, Ph.D is listed as Patients first | Cell and Gene therapies | Ph.D Neuroscientist at Kyverna Therapeutics.
What is Stuart Gibb, Ph.D's email address?
AeroLeads has found 1 work email signal at @terumobct.com for Stuart Gibb, Ph.D at Kyverna Therapeutics.
Where is Stuart Gibb, Ph.D based?
Stuart Gibb, Ph.D is based in San Francisco Bay Area, United States while working with Kyverna Therapeutics.
What companies has Stuart Gibb, Ph.D worked for?
Stuart Gibb, Ph.D has worked for Kyverna Therapeutics, Terumo Blood And Cell Technologies, Cognoa, Terumo Bct, and Bell Biosystems, Inc..
Who are Stuart Gibb, Ph.D's colleagues at Kyverna Therapeutics?
Stuart Gibb, Ph.D's colleagues at Kyverna Therapeutics include Heather Hughes, Tracy Hill, Carrie Iriki, Sham Dholakia, and Russ Bowes.
How can I contact Stuart Gibb, Ph.D?
You can use AeroLeads to view verified contact signals for Stuart Gibb, Ph.D at Kyverna Therapeutics, including work email, phone, and LinkedIn data when available.
What schools did Stuart Gibb, Ph.D attend?
Stuart Gibb, Ph.D holds Doctor Of Philosophy (Ph.D.), Neuroscience from University Of Cambridge.
What skills is Stuart Gibb, Ph.D known for?
Stuart Gibb, Ph.D is listed with skills including Neuronal Cultures, Primary Cells, Molecular Biology, Cell Culture, Cell Biology, Biochemistry, Western Blotting, and Molecular Cloning.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial